Evaluation of circulating endothelial progenitor cells in cardiovascular risk

Circulation Journal

Volumn 75, Issue 11, 2011, Pages 2541-2542

  Fujita, Yasuyuki ^a   Asahara, Takayuki ^b,c  

^a Unit of Regenerative Medicine   (Japan)

^b INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN;

AGING; CARDIOVASCULAR RISK; CELL COUNT; CIRCULATING ENDOTHELIAL PROGENITOR CELL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; EDITORIAL; ENDOTHELIAL PROGENITOR CELL; FAMILY HISTORY; FLOW CYTOMETRY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; PROGNOSIS; SEX DIFFERENCE; SMOKING; STEM CELL MOBILIZATION;

ANTIGENS, CD; BONE MARROW CELLS; DIABETES COMPLICATIONS; FEMALE; GLYCOPROTEINS; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MALE; MYOCARDIAL ISCHEMIA; PEPTIDES; STEM CELLS;

EID: 80054909027     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-1050     Document Type: Editorial

References (17)

1. Flamme I, Risau W. Induction of vasculogenesis and hematopoiesis in vitro. Development 1992; 116: 435-439.
2. Weiss MJ, Orkin SH. In vitro differentiation of murine embryonic stem cells. New approaches to old problems. J Clin Invest 1996; 97: 591-595.
3. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
4. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998; 92: 362-367.
5. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000; 105: 71-77.
6. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952-958.
7. Gunsilius E, Duba HC, Petzer AL, Kahler CM, Grunewald K, Stockhammer G, et al. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet 2000; 355: 1688-1691.
8. Gehling UM, Ergun S, Schumacher U, Wagener C, Pantel K, Otte M, et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000; 95: 3106-3112.
9. Yoder MC. Defining human endothelial progenitor cells. J Thromb Haemost 2009; 7(Suppl 1): 49-52.
10. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: E1-E7.
11. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
12. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999-1007.
13. + bone marrow-derived circulating progenitor cells with an increased number of diseased coronary arteries in ischemic heart disease patients with diabetes. Circ J 2011; 75: 2635-2641.
14. Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990; 81: 491-497.
15. Xiao Q, Kiechl S, Patel S, Oberhollenzer F, Weger S, Mayr A, et al. Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis--results from a large population-based study. PLoS One 2007; 2: e975.
16. + progenitor cells in patients with stable angina pectoris undergoing percutaneous coronary intervention. Circ J 2010; 74: 1929-1935.
17. Masuda H, Alev C, Akimaru H, Ito R, Shizuno T, Kobori M, et al. Methodological development of a clonogenic assay to determine endothelial progenitor cell potential. Circ Res 2011; 109: 20-37.